BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hua F, Shi L, Zhou P. Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases. Inflammopharmacology 2022. [PMID: 35039992 DOI: 10.1007/s10787-021-00918-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 El-sayed S, Freeman S, Bryce RA. A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome. Molecules 2022;27:6213. [DOI: 10.3390/molecules27196213] [Reference Citation Analysis]
2 Habimana O, Modupe Salami O, Peng J, Yi GH. Therapeutic Implications of Targeting Pyroptosis in Cardiac-related Etiology of Heart Failure. Biochem Pharmacol 2022;:115235. [PMID: 36044938 DOI: 10.1016/j.bcp.2022.115235] [Reference Citation Analysis]
3 González-cofrade L, Cuadrado I, Amesty Á, Estévez-braun A, de las Heras B, Hortelano S. Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking. Pharmaceuticals 2022;15:825. [DOI: 10.3390/ph15070825] [Reference Citation Analysis]
4 Wang T, Chai Z, Wang L, Liu B, Zhao J, Ren J, Yang B, Wei X, Jiang L, Liu F. IL-9 blockade attenuates inflammation in a murine model of mechanical ventilation-induced lung injury by inhibiting the NLRP3 inflammasome pathway. Inflammopharmacology 2022. [PMID: 35296962 DOI: 10.1007/s10787-022-00947-7] [Reference Citation Analysis]